Invicta Diagnostic Limited (NSE:INVICTA)
India · Delayed Price · Currency is INR 69.00
-0.05 (-0.07%)
At close: Feb 12, 2026
Invicta Diagnostic Revenue
In the fiscal year ending March 31, 2025, Invicta Diagnostic had annual revenue of 301.81M INR with 89.84% growth. Invicta Diagnostic had revenue of 85.40M in the quarter ending September 30, 2025.
Revenue
301.81M
Revenue Growth
+89.84%
P/S Ratio
2.75
Revenue / Employee
2.87M
Employees
113
Market Cap
829.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 301.81M | 142.83M | 89.84% |
| Mar 31, 2024 | 158.98M | 90.55M | 132.33% |
| Mar 31, 2023 | 68.43M | 39.40M | 135.74% |
| Mar 31, 2022 | 29.03M | - | - |
| Mar 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 7.92B |
| One Global Service Provider | 3.37B |
| Chandan Healthcare | 2.57B |
| Star Imaging and Path Lab | 860.99M |
| Modern Diagnostic & Research Centre | 814.48M |
| Nidan Laboratories and Healthcare | 271.16M |
| Aspira Pathlab & Diagnostics | 242.36M |
| Clinitech Laboratory | 92.39M |